Buy KardiaMobile 6L Personal 6 Lead ECG (FDA Approved) Online for

Buy KardiaMobile 6L Personal 6 Lead ECG (FDA Approved) Online for

4.6
(293)
Escribir comentario
Más
€ 102.99
Añadir al carro
En stock
Descripción

KardiaMobile 6L Personal 6 Lead ECG (FDA Approved) by for Rs15,625

  • The Kardia Mobile 6L device is a heart monitor that allows you to record an electrocardiogram in just 30 seconds using a tablet or smartphone.
  • It allows you to record a complete view of cardiac activity and collects 6 leads: I, II, III, aVR, aVL, aVF.
  • Detects the 3 most common heart arrhythmias: atrial fibrillation, bradycardia, tachycardia
  • Works on Android and iOS devices - Smartphone Compatibilty 

The Kardia Mobile 6L device is a heart monitor that allows you to record an electrocardiogram in just 30 seconds using a tablet or smartphone. It allows you to record a complete view of cardiac activity and collects 6 leads: I, II, III, aVR, aVL, aVF. Detects the 3 most common heart arrhythmias: atrial fibrillation, bradycardia, tachycardia Works on Android and iOS devices - Smartphone Compatibilty 

Mobile ECG: An Objective Comparison of Emay vs Kardia

Buy KardiaMobile 6L Personal 6 Lead ECG (FDA Approved) Online for

Setting up your KardiaMobile 6L – AliveCor Support

INCLUDES DEVICE AND 1 YEAR OF KARDIACARE HEART HEALTH MEMBERSHIP. Get the world's only six-lead personal EKG device plus a KardiaCare membership,

KardiaMobile Personal EKG Heart Rate Monitor – 6 Leads - Record EKGs at Home - Detect Irregular Heartbeats and Irregular Arrhythmias - Includes 1 Year

EKG Monitor with 6 Leads KardiaMobile 6L by AliveCor – AliveCor, Inc.

The screen is large and has high resolution for text and icons that are easy to read. You can also increase the recording duration up to five minutes.

ALIVECOR KARDIAMOBILE 6L MOBILE 6-LEAD EKG BRAND NEW FACTORY SEALED 850214007148

AliveCor's FDA-cleared 6-lead ECG aims to detect more than the Apple Watch - CNET

Alive! Medical Supplies & Equipment

Feasibility of using KardiaMobile-L6 for QT interval monitoring during the early phase of the COVID-19 pandemic in critical care patients